Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 139.50
+5.00 (3.72%)
Sep 14, 2026, 2:02 PM CET
Oncoinvent ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 19.51 | 23.04 | 2.73 | 0.06 | 0.07 | 0.36 |
Other Revenue | 4.8 | 5.03 | 5.37 | 5.73 | 6.22 | 10.72 |
| 24.31 | 28.07 | 8.1 | 5.79 | 6.28 | 11.08 | |
Revenue Growth | 21.58% | 246.40% | 39.95% | -7.85% | -43.31% | 6.80% |
Cost of Revenue | - | - | - | - | - | 0.9 |
Gross Profit | 24.31 | 28.07 | 8.1 | 5.79 | 6.28 | 10.19 |
Selling, General & Admin | 79.92 | 66.65 | 54.65 | 55.74 | 47.34 | 37.56 |
Other Operating Expenses | 111.15 | 108.5 | 79.92 | 86.22 | 61.57 | 48.66 |
Operating Expenses | 199.62 | 186.4 | 149.12 | 153.22 | 116.89 | 91.01 |
Operating Income | -175.31 | -158.33 | -141.02 | -147.43 | -110.61 | -80.83 |
Interest Expense | - | - | - | -0.01 | -0.01 | -0.01 |
Interest & Investment Income | 4.37 | 3.49 | 1.34 | 4.41 | 4.44 | 0.75 |
Currency Exchange Gain (Loss) | -0.82 | -0.82 | -0.65 | -0.6 | -0.11 | - |
Other Non Operating Income (Expenses) | 0.6 | 0.59 | 0.13 | - | - | -0.21 |
Pretax Income | -171.16 | -155.07 | -140.2 | -143.62 | -106.28 | -80.29 |
Net Income | -171.16 | -155.07 | -140.2 | -143.62 | -106.28 | -80.29 |
Net Income to Common | -171.16 | -155.07 | -140.2 | -143.62 | -106.28 | -80.29 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 3 | 1 | 0 | 0 | 0 | 0 |
Shares Change | 403.80% | 395.91% | 28.52% | 0.27% | -2.42% | 38.93% |
EPS (Basic) | -57.11 | -125.13 | -561.04 | -738.62 | -548.04 | -404.00 |
EPS (Diluted) | -57.11 | -125.13 | -561.04 | -738.62 | -548.04 | -404.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -132.74 | -129.99 | -89.75 | -164.94 | -93.17 | - |
Free Cash Flow Per Share | -44.29 | -104.89 | -359.13 | -848.27 | -480.45 | - |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 91.92% |
Operating Margin | -721.06% | -564.07% | -1740.31% | -2546.20% | -1760.48% | -729.27% |
Profit Margin | -704.00% | -552.46% | -1730.24% | -2480.50% | -1691.55% | -724.43% |
Free Cash Flow Margin | -545.98% | -463.11% | -1107.55% | -2848.72% | -1482.94% | - |
EBITDA | -167.29 | -149.8 | -131.81 | -139.84 | -105.82 | -76.04 |
D&A For EBITDA | 8.02 | 8.54 | 9.2 | 7.59 | 4.79 | 4.79 |
EBIT | -175.31 | -158.33 | -141.02 | -147.43 | -110.61 | -80.83 |
Revenue as Reported | 24.31 | 28.07 | 8.1 | 5.79 | 6.28 | 11.08 |
Advertising Expenses | - | - | - | - | - | 0.09 |